REPORT ID 4108

Global Solid Tumor Drug Sales Market Report 2019

Publish Date
2019
Pages
117
Format
Electronic (PDF)

In this report, the global Solid Tumor Drug market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split global into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Solid Tumor Drug for these regions, from   2019 to 2025 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Solid Tumor Drug market competition by top manufacturers/players, with Solid Tumor Drug sales volume, Price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including
    AstraZeneca
    Biogen
    Baxter
    Celgene Corporation
    Abbott Laboratories
    Pfizer Inc
    Amgen Limited & Amgen Ireland Limited
    Bristol-Myers Squibb Company
    GlaxoSmithKline plc.
    F. Hoffmann-La Roche Ltd.
    Eli Lilly and Company
    Johnson & Johnson
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Small Molecules
    Biologics
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Oncology
    Neurology
    Radiology
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Solid Tumor Drug Sales Market  Report 2019
1 Solid Tumor Drug Market Overview
    1.1 Product Overview and Scope of Solid Tumor Drug
    1.2 Classification of Solid Tumor Drug by Product Category
        1.2.1 Global Solid Tumor Drug Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 Global Solid Tumor Drug Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Small Molecules
        1.2.4 Biologics
    1.3 Global Solid Tumor Drug Market by Application/End Users
        1.3.1 Global Solid Tumor Drug Sales (Volume) and Market Share Comparison by Application ( 2014-2024)
        1.3.2 Oncology
        1.3.3 Neurology
        1.3.4 Radiology
        1.3.5 Others
    1.4 Global Solid Tumor Drug Market by Region
        1.4.1 Global Solid Tumor Drug Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 United States Solid Tumor Drug Status and Prospect ( 2014-2024)
        1.4.3 China Solid Tumor Drug Status and Prospect ( 2014-2024)
        1.4.4 Europe Solid Tumor Drug Status and Prospect ( 2014-2024)
        1.4.5 Japan Solid Tumor Drug Status and Prospect ( 2014-2024)
        1.4.6 Southeast Asia Solid Tumor Drug Status and Prospect ( 2014-2024)
        1.4.7 India Solid Tumor Drug Status and Prospect ( 2014-2024)
    1.5 Global Market Size (Value and Volume) of Solid Tumor Drug ( 2014-2024)
        1.5.1 Global Solid Tumor Drug Sales and Growth Rate ( 2014-2024)
        1.5.2 Global Solid Tumor Drug Revenue and Growth Rate ( 2014-2024)

2 Global Solid Tumor Drug Competition by Players/Suppliers, Type and Application
     2.1 Global Solid Tumor Drug Market Competition by Players/Suppliers
        2.1.1 Global Solid Tumor Drug Sales and Market Share of Key Players/Suppliers ( 2014-2019)
        2.1.2 Global Solid Tumor Drug Revenue and Share by Players/Suppliers ( 2014-2019)
    2.2 Global Solid Tumor Drug (Volume and Value) by Type
        2.2.1 Global Solid Tumor Drug Sales and Market Share by Type ( 2014-2019)
        2.2.2 Global Solid Tumor Drug Revenue and Market Share by Type ( 2014-2019)
    2.3 Global Solid Tumor Drug (Volume and Value) by Region
        2.3.1 Global Solid Tumor Drug Sales and Market Share by Region ( 2014-2019)
        2.3.2 Global Solid Tumor Drug Revenue and Market Share by Region ( 2014-2019)
    2.4 Global Solid Tumor Drug (Volume) by Application

3 United States Solid Tumor Drug (Volume, Value and Sales Price)
    3.1 United States Solid Tumor Drug Sales and Value ( 2014-2019)
        3.1.1 United States Solid Tumor Drug Sales and Growth Rate ( 2014-2019)
        3.1.2 United States Solid Tumor Drug Revenue and Growth Rate ( 2014-2019)
        3.1.3 United States Solid Tumor Drug Sales Price Trend ( 2014-2019)
    3.2 United States Solid Tumor Drug Sales Volume and Market Share by Players
    3.3 United States Solid Tumor Drug Sales Volume and Market Share by Type
    3.4 United States Solid Tumor Drug Sales Volume and Market Share by Application

4 China Solid Tumor Drug (Volume, Value and Sales Price)
    4.1 China Solid Tumor Drug Sales and Value ( 2014-2019)
        4.1.1 China Solid Tumor Drug Sales and Growth Rate ( 2014-2019)
        4.1.2 China Solid Tumor Drug Revenue and Growth Rate ( 2014-2019)
        4.1.3 China Solid Tumor Drug Sales Price Trend ( 2014-2019)
    4.2 China Solid Tumor Drug Sales Volume and Market Share by Players
    4.3 China Solid Tumor Drug Sales Volume and Market Share by Type
    4.4 China Solid Tumor Drug Sales Volume and Market Share by Application

5 Europe Solid Tumor Drug (Volume, Value and Sales Price)
    5.1 Europe Solid Tumor Drug Sales and Value ( 2014-2019)
        5.1.1 Europe Solid Tumor Drug Sales and Growth Rate ( 2014-2019)
        5.1.2 Europe Solid Tumor Drug Revenue and Growth Rate ( 2014-2019)
        5.1.3 Europe Solid Tumor Drug Sales Price Trend ( 2014-2019)
    5.2 Europe Solid Tumor Drug Sales Volume and Market Share by Players
    5.3 Europe Solid Tumor Drug Sales Volume and Market Share by Type
    5.4 Europe Solid Tumor Drug Sales Volume and Market Share by Application

6 Japan Solid Tumor Drug (Volume, Value and Sales Price)
    6.1 Japan Solid Tumor Drug Sales and Value ( 2014-2019)
        6.1.1 Japan Solid Tumor Drug Sales and Growth Rate ( 2014-2019)
        6.1.2 Japan Solid Tumor Drug Revenue and Growth Rate ( 2014-2019)
        6.1.3 Japan Solid Tumor Drug Sales Price Trend ( 2014-2019)
    6.2 Japan Solid Tumor Drug Sales Volume and Market Share by Players
    6.3 Japan Solid Tumor Drug Sales Volume and Market Share by Type
    6.4 Japan Solid Tumor Drug Sales Volume and Market Share by Application

7 Southeast Asia Solid Tumor Drug (Volume, Value and Sales Price)
    7.1 Southeast Asia Solid Tumor Drug Sales and Value ( 2014-2019)
        7.1.1 Southeast Asia Solid Tumor Drug Sales and Growth Rate ( 2014-2019)
        7.1.2 Southeast Asia Solid Tumor Drug Revenue and Growth Rate ( 2014-2019)
        7.1.3 Southeast Asia Solid Tumor Drug Sales Price Trend ( 2014-2019)
    7.2 Southeast Asia Solid Tumor Drug Sales Volume and Market Share by Players
    7.3 Southeast Asia Solid Tumor Drug Sales Volume and Market Share by Type
    7.4 Southeast Asia Solid Tumor Drug Sales Volume and Market Share by Application

8 India Solid Tumor Drug (Volume, Value and Sales Price)
    8.1 India Solid Tumor Drug Sales and Value ( 2014-2019)
        8.1.1 India Solid Tumor Drug Sales and Growth Rate ( 2014-2019)
        8.1.2 India Solid Tumor Drug Revenue and Growth Rate ( 2014-2019)
        8.1.3 India Solid Tumor Drug Sales Price Trend ( 2014-2019)
    8.2 India Solid Tumor Drug Sales Volume and Market Share by Players
    8.3 India Solid Tumor Drug Sales Volume and Market Share by Type
    8.4 India Solid Tumor Drug Sales Volume and Market Share by Application

9 Global Solid Tumor Drug Players/Suppliers Profiles and Sales Data
    9.1 AstraZeneca
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Solid Tumor Drug Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 AstraZeneca Solid Tumor Drug Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.1.4 Main Business/Business Overview
    9.2 Biogen
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Solid Tumor Drug Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Biogen Solid Tumor Drug Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.2.4 Main Business/Business Overview
    9.3 Baxter
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Solid Tumor Drug Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Baxter Solid Tumor Drug Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.3.4 Main Business/Business Overview
    9.4 Celgene Corporation
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Solid Tumor Drug Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Celgene Corporation Solid Tumor Drug Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.4.4 Main Business/Business Overview
    9.5 Abbott Laboratories
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Solid Tumor Drug Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Abbott Laboratories Solid Tumor Drug Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.5.4 Main Business/Business Overview
    9.6 Pfizer Inc
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Solid Tumor Drug Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Pfizer Inc Solid Tumor Drug Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.6.4 Main Business/Business Overview
    9.7 Amgen Limited & Amgen Ireland Limited
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Solid Tumor Drug Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.7.4 Main Business/Business Overview
    9.8 Bristol-Myers Squibb Company
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Solid Tumor Drug Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Bristol-Myers Squibb Company Solid Tumor Drug Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.8.4 Main Business/Business Overview
    9.9 GlaxoSmithKline plc.
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Solid Tumor Drug Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 GlaxoSmithKline plc. Solid Tumor Drug Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.9.4 Main Business/Business Overview
    9.10 F. Hoffmann-La Roche Ltd.
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Solid Tumor Drug Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.10.4 Main Business/Business Overview
    9.11 Eli Lilly and Company
    9.12 Johnson & Johnson

10 Solid Tumor Drug Maufacturing Cost Analysis
    10.1 Solid Tumor Drug Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Solid Tumor Drug
    10.3 Manufacturing Process Analysis of Solid Tumor Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Solid Tumor Drug Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Solid Tumor Drug Major Manufacturers  in 2018
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Solid Tumor Drug Market Forecast ( 2019-2025)
    14.1 Global Solid Tumor Drug Sales Volume, Revenue and Price Forecast ( 2019-2025)
       14.1.1 Global Solid Tumor Drug Sales Volume and Growth Rate Forecast ( 2019-2025)
       14.1.2 Global Solid Tumor Drug Revenue and Growth Rate Forecast ( 2019-2025)
       14.1.3 Global Solid Tumor Drug Price and Trend Forecast ( 2019-2025)
    14.2 Global Solid Tumor Drug Sales Volume, Revenue and Growth Rate Forecast by Region ( 2019-2025)
       14.2.1 Global Solid Tumor Drug Sales Volume and Growth Rate Forecast by Regions ( 2019-2025)
       14.2.2 Global Solid Tumor Drug Revenue and Growth Rate Forecast by Regions ( 2019-2025)
       14.2.3 United States Solid Tumor Drug Sales Volume, Revenue and Growth Rate Forecast ( 2019-2025)
       14.2.4 China Solid Tumor Drug Sales Volume, Revenue and Growth Rate Forecast ( 2019-2025)
       14.2.5 Europe Solid Tumor Drug Sales Volume, Revenue and Growth Rate Forecast ( 2019-2025)
       14.2.6 Japan Solid Tumor Drug Sales Volume, Revenue and Growth Rate Forecast ( 2019-2025)
       14.2.7 Southeast Asia Solid Tumor Drug Sales Volume, Revenue and Growth Rate Forecast ( 2019-2025)
       14.2.8 India Solid Tumor Drug Sales Volume, Revenue and Growth Rate Forecast ( 2019-2025)
    14.3 Global Solid Tumor Drug Sales Volume, Revenue and Price Forecast by Type ( 2019-2025)
       14.3.1 Global Solid Tumor Drug Sales Forecast by Type ( 2019-2025)
       14.3.2 Global Solid Tumor Drug Revenue Forecast by Type ( 2019-2025)
       14.3.3 Global Solid Tumor Drug Price Forecast by Type ( 2019-2025)
    14.4 Global Solid Tumor Drug Sales Volume Forecast by Application ( 2019-2025)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer